Details of the Drug Formulations

General Information of Drug (ID: DMIZKOP)

• Drug Name: Thiotepa Drug Info
• Synonyms: thiotepa; THIO-TEPA; 52-24-4; Triethylenethiophosphoramide; Thiophosphamide; Tiofosyl; Tiofosfamid; Thiofozil; Tiofozil; Thioplex; Tespamin; Oncotepa; Tespamine; Girostan; Thiotef; Stepa; Tio-tef; Thio-Tep; Oncotiotepa; Tifosyl; Oncothio-tepa; TESPA; TSPA; Thio-tepa S; Ledertepa; Thiotriethylenephosphoramide; TIO TEF; N,N',N''-Triethylenethiophosphoramide; Tris(1-aziridinyl)phosphine sulfide; Thiophosphamidum; 1,1',1''-phosphorothioyltriaziridine; Triethylene thiophosphoramide; Triaziridinylphosphine sulfide

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Approved	[1]
Immunodeficiency	4A00-4A85	Approved	[2]
Leukemia		Approved	[2]
Urinary bladder cancer		Approved	[2]
Classic Hodgkin lymphoma		Investigative	[2]
Neuroblastoma	2D11.2	Investigative	[2]

• Cross-matching ID:
  PubChem CID: 5453
  ChEBI ID: CHEBI:9570
  CAS Number: 52-24-4
  TTD ID: D00YZA
  VARIDT ID: DR00862
  INTEDE ID: DR1583
  ACDINA ID: D01482

Full List of Drug Formulations Containing This Drug

Thiotepa 15mg lyophilized powder

Company	Formulation ID	FDA Description
Gland Pharma Limited	F23307	Water

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7622).
• [2] Thiotepa FDA Label